• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,699.28 -99.76
(-0.19%)
Dow Jones
7,668.45 9.69
(0.13%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,654.81 -161.33
(-1.49%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

RPG Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532983
INE105J01010
366.0261581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RPGLIFE
39.77
4640.19
EPS(TTM)
Face Value()
Div & Yield %
70.54
8
0.86
 

Nirlon standalone net profit rises 31.85% in the March 2026 quarter
May 25,2026
Net profit of Nirlon rose 31.85% to Rs 70.59 crore in the quarter ended March 2026 as against Rs 53.54 crore during the previous quarter ended March 2025. Sales rose 8.18% to Rs 170.94 crore in the quarter ended March 2026 as against Rs 158.02 crore during the previous quarter ended March 2025.

For the full year,net profit rose 58.57% to Rs 345.98 crore in the year ended March 2026 as against Rs 218.19 crore during the previous year ended March 2025. Sales rose 5.20% to Rs 669.17 crore in the year ended March 2026 as against Rs 636.07 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales170.94158.02 8 669.17636.07 5
OPM %77.4277.84 -77.8979.06 -
PBDT109.7397.37 13 427.53394.74 8
PBT95.5583.91 14 371.95338.41 10
NP70.5953.54 32 345.98218.19 59